Find Academic Supervisors

Jens S. AndersenView profile

Professor

• Proteomics
• Quantitative Mass Spectrometry
• Cell Biology
• +11 more

Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.

Pillai Ramesh ShanmughomView profile

Professor

• Epigenetics
• RNA modifications
• miRNAs
• +5 more

Ramesh Shanmughom Pillai is a Full Professor at the Department of Molecular Biology, University of Geneva, Switzerland. He holds additional roles as a Visiting Professor at the University of Kumamoto, Japan, and has been a Group Leader at EMBL Grenoble and a postdoctoral fellow at the Friedrich Miescher Institute. His research focuses on RNA modifications, epigenetics, and piRNA pathways in germline biology. Pillai has received prestigious awards including the ERC Consolidator Grant and The RNA Society Scaringe Award. Education: BSc Botany (University of Kerala, India) MSc Biotechnology (IIT Roorkee, India) PhD in Cell Biology (University of Bern, Switzerland) Research Interests: Pillai’s work centers on RNA biology, particularly the role of RNA modifications (e.g., m6A, m6Am) in development and fertility. He investigates piRNA biogenesis, transposon silencing, and the molecular mechanisms of RNA-protein interactions. His studies bridge biochemistry, genetics, and structural biology to elucidate how RNA molecules regulate critical biological processes. Teaching & Service: At the University of Geneva, he teaches Molecular Biology courses (BSc/MSc levels) and advises 5 PhD students and 4 postdocs. He chairs the ERC Consolidator Grant Review Panel and organizes major conferences like the PIWI/piRNAs Meeting and Swiss RNA Workshop. Pillai also serves on editorial boards for Nucleic Acids Research and RNA . Awards: ERC Consolidator Grant (2015) Best PhD Thesis Award (2003) RNA Society Scaringe Award (2005) Grants & Labs: Funded by ERC Starting and Consolidator Grants, his lab explores RNA modification networks in germ cells. Former trainees include Professors Simon Conn (Flinders University) and Hao Wu (CAS, China).

• RNA Metabolism
• Non-coding RNAs
• Cancer Metastasis
• +3 more

Claudio R. Alarcón is an Associate Professor in Pharmacology at Yale University School of Medicine. His research focuses on RNA metabolism's role in development, health, and disease, particularly RNA modifications and non-coding RNAs. He joined Yale in 2017 after postdoctoral training at The Rockefeller University and holds a PhD from Cornell University (2009) and a BSc from Pontificia Universidad Católica de Chile (1999). Research Interests: Functional roles of m6A RNA modifications MicroRNA biogenesis and cancer progression Non-coding RNA regulation in metastasis Key Appointments: Primary Faculty, Yale Cancer Biology Institute Member, Yale Cancer Center Faculty, Yale Combined Program in Biological and Biomedical Sciences His lab integrates bioinformatics, molecular, and cellular approaches to study cancer metastasis mechanisms, including miRNA processing disruptions and SOX4/TMEM2 pathways linked to clinical outcomes.

Miler T. LeeView profile

Associate Professor

• Gene Regulation
• Developmental Biology
• Computational Genomics
• +9 more

Miler T. Lee is an Associate Professor at the University of Pittsburgh , focusing on gene regulation during early embryonic development through high-throughput experimental and computational genomics. He earned his Ph.D. in Genomics and Computational Biology in 2009 from the University of Pennsylvania under Dr. Junhyong Kim, followed by postdoctoral work with Dr. Antonio Giraldez at Yale University. Joining the university in 2016, his research spans maternal-to-zygotic transition (MZT), RNA stability, pluripotency networks, and evolutionary developmental biology, utilizing model organisms like zebrafish, Xenopus, and Hydractinia symbiolongicarpus. Key Research Themes: Maternally inherited RNA dynamics during embryogenesis Mechanisms of RNA degradation and transcriptome remodeling Evolution of pluripotency networks in hybrid species Role of zinc signaling in fertilization barriers Computational tools for RNA regulation and sensing Scientific Awards: Pan-American Society for Evolutionary Developmental Biology Junior Faculty Award (2024) Outstanding New Investigator – International Xenopus Board (2023) Basil O'Connor Scholar – March of Dimes (2017-2019) Recent publications highlight his work on enhancer classification, RNA degradation mechanisms, and cross-species MZT comparisons. His lab develops innovative methods like RESA for regulatory sequence analysis and studies evolutionary divergence in RNA localization patterns. While the articles span computational and experimental approaches, they consistently address RNA's role in cellular identity, developmental timing, and evolutionary adaptation. Applications include understanding pluripotency, designing RNA biosensors, and elucidating fertilization barriers. Prospective Ph.D. students are encouraged to contact him for opportunities in gene regulation, development, evo-devo, and computational genomics.

• Nanobiotechnology
• Biophysics
• Colloid and Interface Science
• +4 more

Assoc. Prof. Dietmar Pum is a leading researcher at the Institute of Biophysics, University of Natural Resources and Life Sciences, Vienna (BOKU). With a career spanning over three decades, he has pioneered work on S-layer proteins as nanobiotechnological tools and biomimetic surface functionalization. His research bridges microbiology, biophysics, and nanomaterials science. Education & Career Doctorate (1984) and Habilitation (1992) at Vienna University of Technology Awarded FEBS (1987) and EMBO (1982) fellowships Assoc. Univ. Prof. since 1997, Deputy Head of Biophysics Institute since 2014 Research Focus Dr. Pum's work centers on leveraging S-layer proteins for nanoscale fluid mechanics , molecular imprinting , and biohybrid materials . His projects explore: Self-assembly of 2D protein crystals Functionalization of carbon nanotubes Biomimetic sensor development Applications in diagnostics and environmental technology Publication Trends His recent publications (2025-2019) highlight interdisciplinary advancements in: Nanoscale biofluid dynamics Gold nanoparticle synthesis via microbial enzymes Archaeal S-layer characterization Protein-directed nanomaterials Biosensor platforms Lipid quantification via machine learning Scientific Recognition Philip Morris Research Prize (1998) Cardinal Innitzer Prize (1992) ÖAGM Prize (1986) Peer reviewer for Nature Materials , Advanced Materials , and Biophysical Journal Advising & Collaborations Dr. Pum has supervised over 15 theses, mentoring students in topics ranging from Caenorhabditis elegans imaging to nanomembrane fabrication. He leads international collaborations under EU Horizon and FWF grants, including the Stimuli Responsive Materials project (2020-2025). Labs & Networks As a core member of BOKU's Center for NanoBiotechnology and the Ludwig Boltzmann Institute for Molecular Nanotechnology , he develops bioinspired nanomaterials and contributes to global programs in molecular self-assembly.

ANDREA KASINSKIView profile

Professor

• Non-coding RNA biology
• MicroRNA therapeutics
• Cancer epigenetics
• +3 more

Andrea Kasinski is a Professor of Biological Sciences and Deputy Director of the Purdue Institute for Cancer Research at Purdue University. Her research focuses on non-coding RNAs (microRNAs, lncRNAs, circRNAs) in cancer development and their therapeutic applications. She leads a multidisciplinary team investigating RNA delivery systems, extracellular vesicle biology, and epigenetic regulation in cancer. Key projects include ligand-mediated delivery of miRNAs, exosome-based therapies, and high-throughput screens for miRNA inhibitors. Education: PhD in Molecular & Systems Pharmacology (Emory University, 2009), Postdoctoral Fellowship in Genetics (Yale University, 2013). Awards include NIH Pathway to Independence Award (2013), American Cancer Society Research Scholar (2017), and multiple grants from NIH/NCI (R01 CA205420, R01 CA226259). Her lab has pioneered 'FolamiRs' – folate-targeted miRNA therapeutics – and developed novel strategies for endosomal escape of RNA payloads. Major contributions include identifying miRNA drivers of drug resistance, demonstrating exosome-mediated tumor progression, and advancing miR-34a as a clinical candidate. The lab maintains active collaborations with institutions including Harvard Medical School, MD Anderson Cancer Center, and the National Cancer Institute. Current initiatives focus on KMT5C-mediated epigenetic regulation in EGFR-resistant lung cancers and translational development of fully modified miR-34a (FM-miR-34a).

Ulrike KutayView profile

Professor

• Nuclear envelope structure and biogenesis
• Nucleo-cytoplasmic transport
• Metazoan ribosome biogenesis
• +3 more

Ulrike Kutay is a Full Professor of Biochemistry at ETH Zurich, Switzerland, with a research focus on nuclear biology and dynamics. Her work investigates nuclear envelope structure/function, ribosome biogenesis, and nucleo-cytoplasmic transport. Diploma in Biochemistry (Free University Berlin, 1992) PhD in Natural Sciences (Humboldt University Berlin, 1996) Research interests center on nuclear compartmentalization, including mitotic nuclear envelope breakdown and reassembly, ribosome assembly pathways, and the molecular mechanisms governing nuclear transport. Her lab explores how nuclear dysfunction contributes to diseases like ribosomopathies and cancer. Recent publications highlight her work on SUN/KASH proteins in nuclear envelope dynamics, ribosome biogenesis steps, and nuclear pore complex regulation. Collaborations with groups like the Spahn lab in Berlin underscore her interdisciplinary approach. EMBO Member (2010) Leopoldina Member (2012) ERC Advanced Grant (2012) As a mentor, she has supervised PhD students including Chiara and Roja. She actively participates in editorial boards, grant review panels (e.g., ERC, DFG), and institutional leadership roles at ETH Zurich and the Biochemistry Center Heidelberg. The Kutay Group at ETH Zurich combines proteomics, functional analyses, and structural studies to unravel nuclear processes, fostering a collaborative environment with recent achievements in mitotic nuclear disassembly and ribosome maturation research.

Demian CazallaView profile

Associate Professor

• Non-coding RNA biology
• Gene expression regulation
• Viral oncogenesis
• +3 more

Demian Cazalla is an Associate Professor in the Department of Biochemistry at the University of Utah, focusing on the functional roles of non-coding RNAs (ncRNAs) in gene expression regulation. He is affiliated with the Molecular Biology Program and Biological Chemistry Program, contributing to interdisciplinary research in RNA biology. Education: M.Sc., University of Buenos Aires, Argentina Ph.D., Open University/MRC Human Genetics Unit, Edinburgh, Scotland Dr. Cazalla's research investigates how ncRNAs, particularly those expressed by oncogenic herpesviruses like Herpesvirus saimiri (HVS), regulate gene expression. His lab explores the structural and molecular mechanisms of viral ncRNAs (HSURs), their interactions with host miRNAs, and their role in viral oncogenesis through miRNA degradation and mRNA targeting. Current projects involve biochemical analysis of RNA-protein complexes and high-throughput sequencing to identify RNA targets. His recent publications highlight viral miRNA biogenesis pathways, ncRNA structural dynamics, and RNA-based regulatory networks. The work spans molecular virology, RNA biochemistry, and gene expression control in complex organisms.

Shankar MukherjiView profile

Assistant Professor

• Biophysics
• Quantitative Biology
• Systems Biology
• +3 more

Shankar Mukherji is an Assistant Professor of Physics at Washington University in St. Louis, affiliated with the Department of Physics and the Center for Quantum Leaps. His research integrates theoretical and experimental approaches to understand the design principles governing cellular function, with a focus on organelle biogenesis, spatial organization, and systems-level coordination. He holds a PhD in Biomedical Engineering from the Harvard-MIT Division of Health Science and Technology, and completed postdoctoral training at Harvard’s FAS Center for Systems Biology under Erin O’Shea. Key research themes include: (1) how cells regulate organelle abundance, size, and spatial distribution under developmental/environmental cues, (2) the interplay between organelle biogenesis and cellular physiology, and (3) engineering cellular decision-making to control organelle properties. His group employs advanced imaging, synthetic biology, and computational modeling techniques. Recent work emphasizes systems-level analysis of organelle networks, uncovering principles linking cellular growth to organelle allocation. Notable contributions include studies on stochastic fluctuations in organelle abundance, resource competition models, and the biophysical limits governing organelle formation. Courses taught include Biophysics Laboratory (Physics 360) and Calculus-based Physics (Physics 191). His research has been highlighted in high-impact journals like Cell Systems, Nature, and Science. Current projects explore nanodiamond-based quantum sensing for organelle detection and synthetic biology approaches to reprogram organelle biogenesis pathways.

Sabah HussainView profile

Professor

• Skeletal muscle atrophy and wasting
• Autophagy and mitophagy
• Proteasomal degradation pathways
• +7 more

Sabah Hussain, MD, PhD, is Distinguished James McGill Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University and Senior Scientist in the Translational Research in Respiratory Diseases Program of the Research Institute of the McGill University Health Centre (RI-MUHC, Glen site). She leads an integrated bench-to-bedside program focused on skeletal-muscle wasting, autophagy, and angiogenesis. Education & Training: MD – University of Baghdad, 1978 PhD (Physiology) – McGill University, 1989 Research Focus: Dr Hussain’s laboratory investigates the molecular machinery governing skeletal-muscle mass in health and disease. Using transgenic models of angiopoietin signaling, sepsis, COPD and mechanical ventilation, her team has dissected how autophagy, mitophagy and proteasomal pathways drive diaphragmatic and locomotor muscle atrophy. A second axis of work explores gene-therapy delivery of angiopoietins to accelerate muscle regeneration after injury or in Duchenne Muscular Dystrophy models. More recently, her group is mapping epigenetic regulators—microRNAs and long non-coding RNAs—that fine-tune these degradative pathways. Scientific Awards & Funding: Distinguished James McGill Professorship CIHR Project Grant – Fall 2024 competition NSERC Discovery Grant – 2024 competition Advising & Mentorship: Dr Hussain mentors graduate students, post-doctoral fellows and clinical research trainees. Sami Sedraoui, a PDF in her group, received the April 2025 Relève-Étoile Jacques-Genest Award from CIHR. Laboratory & Affiliations: Her laboratory is located in the Meakins-Christie Laboratories, RI-MUHC Block E, Glen site (1001 Decarie Blvd, Montréal). The group is embedded within the Centre for Translational Biology and benefits from the RI-MUHC Technology Platforms including Proteomics, Small-Animal Imaging and Molecular Imaging Services.

Jean (Jiayu) WenView profile

Associate Professor

• RNA Biology
• Computational Biology
• MicroRNA Regulation
• +5 more

Associate Professor Jean (Jiayu) Wen holds positions at The Australian National University (ANU), including Group Leader of The Wen Group, ARC Future Fellow, and Deputy Director of The Shine-Dalgarno Centre for RNA Innovation. She specializes in computational and molecular biology, focusing on RNA regulation, gene expression, and cancer genomics. Her affiliations include ANU’s Division of Genome Sciences and Cancer, and the Centre for Computational Biomedical Sciences. Education: BEng in Electronic Engineering (Beijing), MSc in Computer Science (Lakehead University), PhD in Computational Biology (ANU). Postdoctoral training at Copenhagen University and Memorial Sloan-Kettering Cancer Center. Research interests span RNA structures, microRNA biogenesis, transcriptome dynamics, and epigenetic regulation. Her work addresses intragenomic conflicts, cancer mechanisms, and neural development. Notable projects include RNA-based machine learning models for RNA-RNA interactions and immune cell differentiation studies. Publications highlight contributions to RNA interference pathways, tumor development, and Drosophila genetics. Awards include the ARC Future Fellowship. She leads interdisciplinary teams advancing computational and experimental approaches in genomics and systems biology.

Phillip D. ZamoreView profile

Professor

• RNA Interference
• Small RNA Biology
• piRNA Pathways
• +3 more

Phillip D. Zamore serves as Chair and Professor of the RNA Therapeutics Institute at the University of Massachusetts Chan Medical School School of Medicine and is an Investigator of the Howard Hughes Medical Institute. He holds the Gretchen Stone Cook Professorship in Biomedical Sciences and leads pioneering research in RNA biology. Dr. Zamore earned his A.B. (1986) and Ph.D. (1992) in Biochemistry and Molecular Biology from Harvard University, followed by postdoctoral training at The Whitehead Institute for Biomedical Research. His research focuses on small RNA silencing pathways including RNA interference (RNAi), microRNA, and PIWI-interacting RNA (piRNA) mechanisms across eukaryotic and prokaryotic systems. Key investigations explore how Argonaute proteins achieve sequence-specific regulation of transcription and translation, with emphasis on piRNA biogenesis in germ cells and bacterial Argonaute functions. Analysis of his recent publications reveals dominant themes in transposon silencing, piRNA pathway evolution, RNA therapeutic development, and molecular mechanisms of gene regulation. His work bridges fundamental biochemistry with clinical applications, particularly in RNA-based therapies for genetic disorders. Notable scientific honors include: Chancellor’s Medal for Excellence in Scholarship (2015) Dean's Award for Research Mentoring (2011) Fellow of the National Academy of Inventors (2014) Election to the American Academy of Arts & Sciences, National Academy of Sciences, and National Academy of Medicine (2023) Dr. Zamore has co-founded multiple biotechnology companies including Alnylam Pharmaceuticals (2002), which developed the FDA-approved RNAi therapeutic ONPATTRO for hereditary transthyretin-mediated amyloidosis, and Voyager Therapeutics (2014). His laboratory has trained dozens of researchers now leading institutions worldwide, with over 150 publications and 119 patents reflecting his translational impact. Current research leverages biochemical and genetic approaches to develop RNA-guided therapies for diseases like Huntington's. The Zamore Laboratory operates within the RNA Therapeutics Institute at UMass Chan Medical School, utilizing advanced genomic, biochemical, and imaging technologies to study small RNA pathways in model organisms including Drosophila, mice, and bacterial systems.

• Molecular Biology
• Biochemistry
• Neurodegenerative Diseases
• +10 more

Dr. Andrey L. Karamyshev is an Associate Professor at the School of Medicine, Texas Tech University Health Sciences Center, in the Department of Cell Biology & Biochemistry. His research focuses on molecular mechanisms of human diseases, particularly neurodegenerative disorders and cancer, through the lens of protein synthesis regulation and quality control. Academic Rank: Associate Professor Research Affiliation: Institute for One Health Innovation Research Interests include: Molecular mechanisms of translational regulation RNA and protein quality control Protein interactions in health and disease Signal Recognition Particle (SRP) dysfunction in neurodegenerative diseases Role of AGO2 in mRNA degradation Co-translational protein folding and targeting Recent Publications highlight his work on the RAPP pathway, SRP interactions in Leishmania, and protein misfolding in Parkinson’s and Alzheimer’s diseases. His studies integrate in vivo and in vitro methodologies, including photo-crosslinking and iPINCH techniques. Scientific Awards & Recognition : Featured in Trends in Biochemical Sciences (2014) Highlighted in Nature Reviews Genetics (2014) Recommended by Faculty of 1000 (F1000Prime) for multiple publications Top 5.0% viewed/downloaded article in Frontiers (2018) Dr. Karamyshev welcomes graduate students to his lab, emphasizing collaboration and innovative research in molecular biology and biomedical sciences. His lab is affiliated with the Institute for One Health Innovation, fostering interdisciplinary approaches to human disease treatment.

Gregory J. HannonView profile

Professor

• Small RNA Biology
• RNA Interference
• Cancer Biology
• +7 more

Gregory J. Hannon is a distinguished Professor at Cold Spring Harbor Laboratory (CSHL) and an Investigator of the Howard Hughes Medical Institute, renowned as one of the world's foremost authorities on small RNA biology and RNA interference. His research has significantly advanced our understanding of gene regulation mechanisms with profound implications for cancer treatment and genome stability. Hannon's educational background includes training that led to his current position as a leading molecular biologist. His research focuses on the biological roles of small RNAs and the mechanisms by which they operate, with particular emphasis on germ cells (which have the most elaborate set of small RNA pathways) and cancer biology (especially breast and pancreatic cancer). His laboratory's groundbreaking work has identified and characterized major biogenesis and effector complexes for small interfering RNAs and microRNAs, including Dicer, RISC, and elements of the Microprocessor. More recently, his team has made significant discoveries regarding piwi-interacting RNAs (piRNAs) and their role in defending the genome from mobile genetic elements. Among his most significant publications are studies on the structure of human Argonaute protein, mechanisms of transposon defense in germ cells, and how breast tissue 'remembers' a first pregnancy through epigenetic changes. His research has consistently appeared in top-tier journals, with several publications recognized by Science as 'Breakthrough of the Year.' Elected to National Academy of Sciences (2012) NIH MERIT Award from National Institute of General Medical Sciences (2013) National Academy of Sciences Award in Molecular Biology (2007) Geoffrey Marshall Mentoring Award from Northeastern Association of Graduate Schools (2011) Howard Hughes Medical Institute Investigator Hannon has mentored 12 postdoctoral fellows and 17 graduate students, with exceptional outcomes including multiple prestigious awards for his trainees. Over 60% of his 200+ publications include graduate student co-authorship. His laboratory has developed innovative technologies including RNAi libraries targeting entire genomes and methods used in Neanderthal genome sequencing. He also serves as director of the Cancer Research UK Cambridge Institute, demonstrating his international leadership in cancer research.

• Trypanosomiasis
• Trypanosoma brucei
• Mitochondrial Biology
• +3 more

Minu Chaudhuri, PhD, is a Professor in the Department of Microbiology, Immunology, and Physiology at the School of Medicine, Meharry Medical College. Her research focuses on mitochondrial biology in Trypanosoma brucei, the parasite responsible for African trypanosomiasis, with particular emphasis on protein trafficking mechanisms and cellular homeostasis. She is affiliated with the Health Disparities Research Center of Excellence. Research Themes: Dr. Chaudhuri's work addresses fundamental questions in mitochondrial function, including protein import pathways, translocase machinery roles, and the interplay between redox signaling and epigenetic regulation in cancer. Her studies on Trypanosoma brucei explore mechanisms enabling parasitic survival and pathogenesis, with implications for drug development. Publications Highlights: Recent work includes groundbreaking reviews on Tim17 protein complexes and discoveries about novel mitochondrial import pathways in trypanosomes. Her cancer research identifies redox/miRNA axes that regulate tumor suppressor genes like BRCA2, offering new therapeutic targets. Awards & Grants: No honors or grants explicitly listed in the provided text. Her research is supported through institutional affiliations and collaborative grants. Labs & Teams: Leads a research group focused on parasitology and mitochondrial biology, collaborating with institutions like the Health Disparities Research Center of Excellence to translate basic science findings into public health solutions.